PMID- 27408805 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20160713 LR - 20201001 IS - 2213-3232 (Print) IS - 2213-3232 (Electronic) IS - 2213-3232 (Linking) VI - 6 DP - 2016 TI - Nonconvulsive status epilepticus cases arising in connection with cephalosporins. PG - 23-7 LID - 10.1016/j.ebcr.2016.04.005 [doi] AB - Cephalosporins, particularly cefepime, exert neurotoxic side effects that can lead to status epilepticus. These neurotoxic side effects include myoclonus, dystonic movements, tremor, asterixis, seizure, status epilepticus, encephalopathy, and sometimes coma. Status epilepticus, particularly nonconvulsive status epilepticus (NCSE), is a well-known but unusual complication in patients with altered renal function who were receiving treatment with intravenous cephalosporins, especially cefepime. We reviewed the clinical and electroencephalographic (EEG) characteristics of 7 patients with renal failure who developed consciousness alterations with changes in EEG activity while being treated with cephalosporins. All patients developed renal failure: six patients had chronic renal failure, one patient had acute renal failure, and two patients were administered hemodialysis. Nonconvulsive status epilepticus was observed between 2 and 8 days (average of 5.6 days) after initiation of cephalosporins. Cephalosporins are epileptogenic drugs, especially when used in excessive doses or when renal function is impaired. Critically ill patients with chronic kidney disease are particularly susceptible to cefepime neurotoxicity. Clinical and electrophysiological results of patients guide the diagnosis of NCSE by healthcare providers. FAU - Bora, Ibrahim AU - Bora I AD - Uludag University Medical School, Neurology Department, 16059 Gorukle, Bursa, Turkey. FAU - Demir, Aylin Bican AU - Demir AB AD - Uludag University Medical School, Neurology Department, 16059 Gorukle, Bursa, Turkey. FAU - Uzun, Pinar AU - Uzun P AD - Uludag University Medical School, Neurology Department, 16059 Gorukle, Bursa, Turkey. LA - eng PT - Journal Article DEP - 20160520 PL - United States TA - Epilepsy Behav Case Rep JT - Epilepsy & behavior case reports JID - 101614202 PMC - PMC4925880 OTO - NOTNLM OT - Cephalosporin OT - Nonconvulsive status epilepticus OT - Prognosis OT - Treatment EDAT- 2016/07/14 06:00 MHDA- 2016/07/14 06:01 PMCR- 2016/05/20 CRDT- 2016/07/14 06:00 PHST- 2016/03/28 00:00 [received] PHST- 2016/04/11 00:00 [revised] PHST- 2016/04/30 00:00 [accepted] PHST- 2016/07/14 06:00 [entrez] PHST- 2016/07/14 06:00 [pubmed] PHST- 2016/07/14 06:01 [medline] PHST- 2016/05/20 00:00 [pmc-release] AID - S2213-3232(16)30019-6 [pii] AID - 10.1016/j.ebcr.2016.04.005 [doi] PST - epublish SO - Epilepsy Behav Case Rep. 2016 May 20;6:23-7. doi: 10.1016/j.ebcr.2016.04.005. eCollection 2016.